BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 4364687)

  • 1. Mutant phosphoribosylpyrophosphate synthetase in two gouty siblings with excessive purine production.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Adv Exp Med Biol; 1973; 41():299-305. PubMed ID: 4364687
    [No Abstract]   [Full Text] [Related]  

  • 2. Human erythrocyte phosphoribosylpyrophosphate synthetase mutationally altered in regulatory properties.
    Sperling O; Persky-Brosh S; Boer P; De Vries A
    Biochem Med; 1973 Jun; 7(3):389-95. PubMed ID: 4351826
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased PP-ribose-P synthetase activity: a genetic abnormality leading to excessive purine production and gout.
    Becker MA; Meyer LJ; Kostel PJ; Seegmiller JE
    Adv Exp Med Biol; 1973; 41():307-15. PubMed ID: 4364688
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration and synthesis of phosphoribosylpyrophosphate in erythrocytes from normal, hyperuricemic, and gouty subjects.
    Meyskens FL; Williams HE
    Metabolism; 1971 Aug; 20(8):731-42. PubMed ID: 4327978
    [No Abstract]   [Full Text] [Related]  

  • 5. Purine overproduction in man associated with increased phosphoribosylpyrophosphate synthetase activity.
    Becker MA; Meyer LJ; Wood AW; Seegmiller JE
    Science; 1973 Mar; 179(4078):1123-6. PubMed ID: 4347565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered kinetic property of erythrocyte phosphoribosylpsyrophosphate synthetase in excessive purine production.
    Sperling O; Boer P; Persky-Brosh S; Kanarek E; De Vries A
    Rev Eur Etud Clin Biol; 1972; 17(7):703-6. PubMed ID: 4346548
    [No Abstract]   [Full Text] [Related]  

  • 7. Identification and isolation on a large scale of guanylate kinase from human erythrocytes. Effects of monophosphate nucleotides of purine analogs.
    Agarwal RP; Scholar EM; Agarwal KC; Parks RE
    Biochem Pharmacol; 1971 Jul; 20(7):1341-54. PubMed ID: 5163075
    [No Abstract]   [Full Text] [Related]  

  • 8. Mutant feedback-resistant phosphoribosylpyrophosphate synthetase associated with purine overproduction and gout. Phosphoribosylpyrophosphate and purine metabolism in cultured fibroblasts.
    Zoref E; De Vries A; Sperling O
    J Clin Invest; 1975 Nov; 56(5):1093-9. PubMed ID: 171280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. X-linked pattern of inheritance of gout due to mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Zoref E; de Vries A; Sperling O
    Adv Exp Med Biol; 1977; 76A():287-92. PubMed ID: 193372
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic defects of primary hyperuricemia and gout.
    Wyngaarden JB
    Am J Med; 1974 May; 56(5):651-64. PubMed ID: 4363475
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of the role of 5-phosphoribosyl-alpha-1-pyrophosphate synthetase in congenital hyperuricemia and gout: a simple isotopic assay and an activity stain for the enzyme.
    Johnson MG; Rosenweig S; Switzer RL; Becker MA; Seegmiller JE
    Biochem Med; 1974 Jul; 10(3):266-75. PubMed ID: 4366297
    [No Abstract]   [Full Text] [Related]  

  • 12. [Phosphoribosylpyrophosphate synthetase anomalies in 2 cases of gout beginning at an early age].
    Lejeune E; Bouvier M; Mousson B; Llorca G; Baltassat P
    Rev Rhum Mal Osteoartic; 1979; 46(7-9):457-65. PubMed ID: 228383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human phosphoribosylpyrophosphate synthetase. Distribution, purification, and properties.
    Fox IH; Kelley WN
    J Biol Chem; 1971 Sep; 246(18):5739-48. PubMed ID: 4328836
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of a feedback-resistant phosphoribosylpyrophosphate synthetase from cultured, mutagenized hepatoma cells that overproduce purines.
    Green CD; Martin DW
    Proc Natl Acad Sci U S A; 1973 Dec; 70(12):3698-702. PubMed ID: 4359485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of the synthesis of 5-phosphoribosyl-I-pyrophosphate in intact red blood cells and in cell-free preparations.
    Hershko A; Razin A; Mager J
    Biochim Biophys Acta; 1969 Jun; 184(1):64-76. PubMed ID: 4307186
    [No Abstract]   [Full Text] [Related]  

  • 16. Overproduction disease in man due to enzyme feedback resistance mutation. Purine overproduction in gout due to excessive activity of mutant feedback-resistant phosphoribosylpyrophosphate synthetase.
    Sperling O; Boer P; Brosh S; Zoref E; de Vries A
    Enzyme; 1978; 23(1):1-9. PubMed ID: 203449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophoretic separation of normal and mutant phosphoribosylpyrophosphate synthetase.
    Boer P; Sperling O; De Vries A
    Adv Exp Med Biol; 1974; 41():807-9. PubMed ID: 4364981
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of phosphoribosylpyrophosphate synthesis in human lymphocytes.
    Garcia RC; Leoni P; Allison AC
    Biochem Biophys Res Commun; 1977 Aug; 77(3):1067-73. PubMed ID: 197945
    [No Abstract]   [Full Text] [Related]  

  • 19. Human phosphoribosylpyrophosphate synthetase. Kinetic mechanism and end product inhibition.
    Fox IH; Kelley WN
    J Biol Chem; 1972 Apr; 247(7):2126-31. PubMed ID: 4335863
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of phosphoribosylpyrophosphate and ribose-5-phosphate concentration and generation in fibroblasts from patients with gout and purine overproduction.
    Becker MA
    J Clin Invest; 1976 Feb; 57(2):308-18. PubMed ID: 176178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.